Virus News and Research

Latest Virus News and Research

Alfred Blalock’s medical breakthroughs have been saving many lives

The year was 1925, and Alfred Blalock was already a failure at age 26. The born-and-raised Georgian earned a bachelor's degree from the University of Georgia in 1918, then a medical doctorate from Johns Hopkins University four years later. But he didn't get the surgical residency he coveted at Hopkins; he ended up interning in urology instead.

29 Mar 2018

Researchers create synthesized nanosheets to inactivate or detect pathogens

Researchers have developed a process for creating ultrathin, self-assembling sheets of synthetic materials that can function like designer flypaper in selectively binding with viruses, bacteria, and other pathogens.

29 Mar 2018

Study shows limitations of AAV gene therapy in treating hereditary adrenal disorders

A new study has definitively shown that a single treatment with gene therapy using adeno-associated viral (AAV) vector gene delivery to replace the defective gene responsible for congenital adrenal hyperplasia (CAH) will only temporarily alleviate the hereditary disorder.

29 Mar 2018

Tiny biochip holds promise for rapid and accurate disease detection

A novel invention by a team of researchers from the National University of Singapore (NUS) holds promise for a faster and cheaper way to diagnose diseases with high accuracy.

29 Mar 2018

UBC researchers unveil representative of most abundant giant viruses in the sea

Bodo saltans virus, the first isolated representative of the most abundant giant viruses in the sea, has been unveiled by researchers at the University of British Columbia.

29 Mar 2018

Scientists identify early markers of infection in nonhuman primates exposed to Ebola virus

Scientists have identified potential biomarkers in nonhuman primates exposed to Ebola virus (EBOV) that appeared up to four days before the onset of fever, according to research published today in the journal Science Translational Medicine.

28 Mar 2018

Phase I clinical trial of HIV vaccines to begin in the U.S.

A Phase I clinical trial testing the safety of vaccines that might have the potential to prevent HIV infection will begin this month at four sites in the United States, marking the latest step in a three-decade quest at UMass Medical School to harness the power of DNA vaccines in addressing a major global health threat.

28 Mar 2018

New test detects Zika antibodies with high specificity

A test that detects antibodies against Zika virus in samples of blood serum with high specificity - and hence a low risk of cross-reaction with related microorganisms such as dengue virus - is set to come on to the Brazilian market before 2018 is out.

28 Mar 2018

Lassa fever epidemic in Nigeria beginning to slow, but concern remains

After nearly 400 confirmed infections and 100 deaths, the spread of Lassa fever in Nigeria is beginning to slow but the epidemic is far from contained, the World Health Organization and the Nigeria Centre for Disease Control have warned.

28 Mar 2018

New long-acting delivery system has potential to lessen side effects from NRTIs

An HIV diagnosis, while no longer constituting a death sentence, brings with it a lifetime, daily regimen of medication to help continually combat the virus.

27 Mar 2018

Antibiotic use linked to higher risk of severe viral disease in mice

People infected with West Nile virus can show a wide range of disease. Some develop life-threatening brain infections. Others show no signs of infection at all. One reason for the different outcomes may lie in the community of microbes that populate their intestinal tracts.

27 Mar 2018

Study identifies genetic factors linked to severity of acute viral bronchiolitis

A scientific study conducted at the State University of Campinas (UNICAMP) in São Paulo State, Brazil, has identified genetic factors associated with the severity of acute viral bronchiolitis. The study was supported by the Sao Paulo Research Foundation - FAPESP. Its results were published in the journal Gene.

27 Mar 2018

Study finds low hepatitis C virus screening rates among baby boomers

Despite the steady increase of liver cancer incidence in the United States in recent decades, data from 2015 indicates that less than 13 percent of individuals born between 1945 and 1965 are estimated to have undergone screening for hepatitis C virus (HCV).

27 Mar 2018

Researchers aim to accurately identify aggressive oropharyngeal cancers

The Case Western Reserve-led research team will analyze computerized images of tissue samples for patterns which could become "biomarkers," or predictors, for determining relative risk for recurrence in one particularly common type of head and neck cancers.

27 Mar 2018

Experts highlight urgent need to prevent infections in patients undergoing hemodialysis

Patients with kidney failure who are treated with hemodialysis are at substantially increased risk of life-threatening infections.

23 Mar 2018

Novel vaccine technologies can help better prepare for future infectious disease threats

Novel vaccine technologies are critical to improving the public health response to infectious disease threats that continually emerge and re-emerge, according to scientists at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

22 Mar 2018

Discovery of genes could lead to development of novel therapies for EBV-related cancers

VCU Massey Cancer Center researchers have identified two genes that are responsible for governing the replication of the Epstein-Barr virus, an infection that drives the growth of several types of cancer.

21 Mar 2018

Sartorius Stedim Biotech selected by ABL Europe to supply single-use process technologies

Sartorius Stedim Biotech S.A., a leading international technology partner of the biopharmaceutical industry, has been selected by ABL Europe as its primary supplier of single-use systems.

From Sartorius 21 Mar 2018

Adults skipping vaccines may miss out on effective new shingles shot

Federal officials have recommended a new vaccine that is more effective than an earlier version at protecting older adults against the painful rash called shingles. But persuading many adults to get this and other recommended vaccines continues to be an uphill battle, physicians and vaccine experts say.

20 Mar 2018

Measles alert after two passengers with the disease fly into US

Vulnerable persons who have not been vaccinated for measles and have been through airports in Newark, New Jersey, Detroit and Memphis this month are being warned about the possible risk of measles by the health officials. They have announced that two air passengers from overseas were confirmed to have had measles and were travelling via these airports.

18 Mar 2018

Virus News and Research

Latest Virus News and Research

Alfred Blalock’s medical breakthroughs have been saving many lives

Researchers create synthesized nanosheets to inactivate or detect pathogens

Study shows limitations of AAV gene therapy in treating hereditary adrenal disorders

Tiny biochip holds promise for rapid and accurate disease detection

UBC researchers unveil representative of most abundant giant viruses in the sea

Scientists identify early markers of infection in nonhuman primates exposed to Ebola virus

Phase I clinical trial of HIV vaccines to begin in the U.S.

New test detects Zika antibodies with high specificity

Lassa fever epidemic in Nigeria beginning to slow, but concern remains

New long-acting delivery system has potential to lessen side effects from NRTIs

Antibiotic use linked to higher risk of severe viral disease in mice

Study identifies genetic factors linked to severity of acute viral bronchiolitis

Study finds low hepatitis C virus screening rates among baby boomers

Researchers aim to accurately identify aggressive oropharyngeal cancers

Experts highlight urgent need to prevent infections in patients undergoing hemodialysis

Novel vaccine technologies can help better prepare for future infectious disease threats

Discovery of genes could lead to development of novel therapies for EBV-related cancers

Sartorius Stedim Biotech selected by ABL Europe to supply single-use process technologies

Adults skipping vaccines may miss out on effective new shingles shot

Measles alert after two passengers with the disease fly into US

A new way of characterising biomolecules eBook

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Newsletters you may be interested in